Personally: I’d limit my defense of A-Rod to one centering on the disproportionate suspension he received rather than argue that he didn’t take any PEDs at all. Partially because of what the Biogenesis documents are reported to contain, partially because no one else associated with Biogenesis has claimed that they didn’t do it and partially because I don’t feel like I’d trust A-Rod enough to take his word for it.
Oh, also: I don’t feel like a lot of other people would buy it either. Better to err on the side of plausibility, yes?
Well, I’m not Joe Tacopina. And Mr. Tacopina is known to take bold stances. He’s doing so again:
Tacopina told CNN that Rodriguez had “absolutely not” taken illegal PEDs recently and challenged the notion that MLB possesses any evidence to the contrary.
As we’ve seen in the past, it’s possible to parse the term “illegal” in the phrase “illegal PEDs.” MLB bans lots of things, after all, that you, I or anyone else can go purchase at GNC or get from a physician. There’s also that whole bit about how stuff that is illegal here is not illegal in other countries. There’s also the fact that a lawyer saying something to CNN is different than actually arguing such a thing in an arbitration and that Tacopina has been all about the P.R. aspects of this case for some time.
Still, pretty interesting tack to take. As is some of the stuff in the linked article describing how this case is turning into a battle between MLB and A-Rod to portray the other as being sleazier in its efforts to obtain evidence.
Former Tigers infielder Casey McGehee has reportedly signed a one-year deal with the Yomiuri Giants of Nippon Professional Baseball, according to FOX Sports’ Ken Rosenthal.
It’s the fourth move the corner infielder has made in the last two seasons after seeing short-term stints with the Marlins, Giants and Tigers. He signed a minor league deal with the Tigers prior to the 2016 season, providing the club with some infield depth behind 24-year-old Nick Castellanos. When Castellanos hit the disabled list in August with a broken hand, McGehee was recalled from Triple-A Toledo for a 30-game stint and slashed .228/.260/.239 with one extra-base hit in 96 PA. His career batting line (.258/.317/.384 over eight seasons) isn’t too shabby, but his age and a long history of knee injuries puts a damper on his potential.
McGehee last appeared in the NPB circuit in 2013, when he signed a one-year, $1.5 million deal with the Tohoku Rakuten Golden Eagles. He spent the bulk of his season at the hot corner, batting an impressive .292/.396/.515 with 28 homers in 590 PA and appearing in the Eagles’ first and only championship run to date.
The deal comes with a club option for 2018, Rosenthal reports, though no figure has been specified.
Free agent left-hander Rich Hill is rumored to be entertaining a three-year, $40+ million offer from the Dodgers, reports Peter Gammons. The Boston Globe’s Nick Cafardo corroborated the report, adding that Hill could receive somewhere between $46 and $48 million from his former team.
Hill, 36, pitched to a 2.12 ERA and 3.91 FIP in back-to-back stints with the Athletics and Dodgers in 2016. While a chronic case of blisters on his pitching hand limited the frequency of his starts, he still figures to be one of the most productive and noteworthy starting pitchers on the market this winter.
The Orioles, Yankees, Red Sox, Rangers and Astros have all been mentioned as potential suitors for the left-hander’s services, though Orioles’ GM Dan Duquette said the club has yet to make a play for Hill and ESPN’s Jim Bowden pointed out that the Red Sox are less involved in trade talks than other interested parties.